SPRUCE BIOSCIENCES, INC.

For the period ended Jun 30, 2026. Filed Aug 12, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 12, 2026

SPRB$46.67-5.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Statements of Stockholders’ Equity

(in thousands, except share amounts)

Additional · Total
Common Stock · Paid-In · Accumulated · Stockholders'
	Shares	Amount	Capital	Deficit	Equity
Balance as of April 1, 2026	1,372,278	$—	$336,148	$(301,500)	$34,648
Issuance of common stock and warrants, net of offering costs of $4,562	1,380,000	—	64,438	—	64,438
Issuance of common stock related to employee stock purchase plan	532	—	2	—	2
Stock-based compensation	—	—	871	—	871
Net loss	—	—	—	(16,229)	(16,229)
Balance as of June 30, 2026	2,752,810	$—	$401,459	$(317,729)	$83,730

Additional · Total
Common Stock · Paid-In · Accumulated · Stockholders'
	Shares	Amount	Capital	Deficit	Equity
Balance as of January 1, 2026	1,372,043	$—	$331,750	$(289,234)	$42,516
Issuance of common stock and warrants, net of offering costs of $4,562	1,380,000	—	64,438	—	64,438
Issuance of common stock related to employee stock purchase plan	532	—	2	—	2
Issuance of common stock related to vesting of restricted stock units, net of tax withholdings	235	—	(10)	—	(10)
Reclassification of embedded conversion option	—	—	3,719	—	3,719
Stock-based compensation	—	—	1,560	—	1,560
Net loss	—	—	—	(28,495)	(28,495)
Balance as of June 30, 2026	2,752,810	$—	$401,459	$(317,729)	$83,730

Additional · Total
Common Stock · Paid-In · Accumulated · Stockholders'
	Shares	Amount	Capital	Deficit	Equity
Balance as of April 1, 2025	563,042	$—	$279,633	$(264,309)	$15,324
Stock-based compensation	—	—	(77)	—	(77)
Net loss	—	—	—	(2,067)	(2,067)
Balance as of June 30, 2025	563,042	$—	$279,556	$(266,376)	$13,180

Additional · Total
Common Stock · Paid-In · Accumulated · Stockholders'
	Shares	Amount	Capital	Deficit	Equity
Balance as of January 1, 2025	563,042	$—	$279,089	$(250,268)	$28,821
Stock-based compensation	—	—	467	—	467
Net loss	—	—	—	(16,108)	(16,108)
Balance as of June 30, 2025	563,042	$—	$279,556	$(266,376)	$13,180

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.